While earnings season is under way, investors in biotech stocks must also stay abreast of the latest data emerging from major medical meetings. At these events, biotech and pharmaceutical companies vie for top billing to showcase the latest results on clinical trials and new drug candidates.
The American Society of Nephrology Annual Meeting, also known as Kidney Week, will take place from Nov. 5-10 in Washington, D.C. Three companies presenting data at the event -- Apellis (NASDAQ: APLS), Reata Pharmaceuticals (NASDAQ: RETA), and Retrophin (NASDAQ: RTRX) -- are particularly compelling as investments. Here's why.
Image Source: Getty Images.